You are here

Merck

FDA Grants Merck Priority Review for Keytruda Drug (MRK)

Investopedia

Mon, 11/28/16 - 09:56 am

priority review

non-small cell lung cancer

$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market

Motley Fool

Mon, 11/21/16 - 02:35 pm

Alzheimer's disease

BACE inhibitors

Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class

Market Realist

Mon, 11/21/16 - 11:39 am

Bristol-Myers Squibb

Understanding Bristol’s Blockbuster: Opdivo’s Edge over Keytruda

Market Realist

Sat, 11/19/16 - 11:17 am

Bristol-Myers Squibb

Bristol's Bid To Get Ahead In Head And Neck

Seeking Alpha

Tue, 11/15/16 - 09:17 am

Bristol-Myers Squibb

head and neck cancer

Merck Reports Triple-Combo Results

https://yhoo.it/2fT1k83

Mon, 11/14/16 - 10:38 pm

U.S. Charges in Generic-Drug Probe to Be Filed by Year-End

Bloomberg

Fri, 11/4/16 - 09:42 am

Merck can’t prove its Alzheimer’s drug works, yet, but it did just explain why it’s spending a fortune on PhIII

Endpoints

Thu, 11/3/16 - 09:49 am

Alzheimer's disease

clinical trials

Gardasil Is Driving Merck’s Vaccines Business

Market Realist

Mon, 10/31/16 - 09:09 am

Can Keytruda Return Merck & Co. to Growth?

Motley Fool

Sun, 10/30/16 - 11:22 am

Could This Look-A-Like Drug Be Merck's Next Big Seller?

Motley Fool

Sat, 10/29/16 - 01:21 pm

Merck and Novartis chiefs outline what’s on the M&A menu in 2017

Endpoints

Wed, 10/26/16 - 09:14 am

Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More than 30 Data Presentations at ID Week 2016

Yahoo

Wed, 10/26/16 - 09:05 am

infectious diseases

Gardasil propelled Merck to a strong third quarter — but don’t expect that to last

Marketwatch

Tue, 10/25/16 - 03:52 pm

Merck quarterly revenue beats, raises full-year forecast

Yahoo/Reuters

Tue, 10/25/16 - 10:25 am

Word on the Street about Merck’s Animal Health Segment

Market Realist

Tue, 10/25/16 - 10:00 am

FDA approves Merck's lung cancer drug as first-line treatment

Yahoo/Reuters

Mon, 10/24/16 - 11:56 pm

metastatic non-small cell lung cancer

What to Expect From Merck Earnings

Yahoo/24-7 Wall St

Mon, 10/24/16 - 11:52 pm

Merck, Bristol-Myers set to compete in bladder cancer

BioPharma Dive

Mon, 10/24/16 - 11:43 pm

Bristol-Myers Squibb

Facing Cubicin generic threat, Merck's antibiotics biz gets a nudge with new C. diff-fighter Zinplava

Fierce Pharma

Mon, 10/24/16 - 09:52 am

Pages